Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

SmartPharm

SmartPharm is a biotechnology firm that researches and develops gene-encoded therapeutic for the treatment of cancer and orphan diseases. Read more

3 Followers on Owler
3 Followers on Owler
3 Followers on Owler
3 Followers on Owler

SmartPharm

SmartPharm is a biotechnology firm that researches and develops gene-encoded therapeutic for the treatment of cancer and orphan diseases. Read more

Jose Trevejo's photo - President & CEO of SmartPharm

President & CEO

Jose Trevejo

CEO Approval Rating

90/100

Founded:

2017

Status:

PrivateSubsidiary of Sorrento Therapeutics, Inc.

Website:

Est. Annual Revenue
Est. Employees
Sector
Biotechnology
Headquarters

SMARTPHARM TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

SmartPharm's top 3 competitors are REGENXBIO, Recombinetics and Precision BioSciences. Together they have raised over 616.8M between their estimated 571 employees. SmartPharm's revenue is the ranked 3rd among it's top 10 competitors. The top 10 competitors average 39M. SmartPharm has 25 employees and is ranked 4th among it's top 10 competitors. The top 10 competitors average 120.

REGENXBIO is the top competitor of SmartPharm. REGENXBIO was founded in 2009, and its headquarters is in Rockville, Maryland. Like SmartPharm, REGENXBIO also operates in the Biotechnology field. REGENXBIO has 281 more employees than SmartPharm.

Recombinetics is seen as one of SmartPharm's top competitors. Recombinetics was founded in Saint Paul, Minnesota} in 2008. Like SmartPharm, Recombinetics also works within the Biotechnology field. Compared to SmartPharm, Recombinetics generates $5.5M more revenue.

Precision BioSciences is SmartPharm's #3 rival. Precision BioSciences's headquarters is in Durham, North Carolina, and was founded in 2006. Like SmartPharm, Precision BioSciences also operates in the Biotechnology sector. Precision BioSciences generates 1,194% of SmartPharm's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $1.7M a good estimate for SmartPharm's revenue?

I don't know

SmartPharm Acquisitions

No recent acquisitions found related to SmartPharm

SmartPharm Funding History

$10.5M$10.7M

Since SmartPharm was founded in 2017, it has participated in 2 rounds of funding. In total SmartPharm has raised $10.7M. SmartPharm's last funding round was on Apr 2020 for a total of $150.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt - PPP (CARES Act)
Apr 2020
$150K - $350K

U.S. Small Business Administration.

Equity
Jan 2018
$10.5M
-

Total Funding: $10.7M

Since SmartPharm was founded in 2017, it has participated in 2 rounds of funding. In total SmartPharm has raised $10.7M. SmartPharm's last funding round was on Apr 2020 for a total of $150.0K

SmartPharm Investments

No recent investments found related to SmartPharm

SmartPharm News

August 21, 2020Zacks

Sorrento to Buy Privately-Held SmartPharm to Boost Pipeline

Sorrento (SRNE) signs agreement to acquire SmartPharm Therapeutics in exchange for its common stock w... See more »
August 20, 2020Seeking Alpha

Sorrento inks merger agreement with SmartPharm

See more »
March 23, 2020BioSpace

SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19Collaboration to leverage synergies between Monoclonal Antibody and Non-Viral Gene Delivery Platforms

In response to the government call for rapidly deployable countermeasures, Sorrento Therapeutics, Inc... See more »
March 23, 2020FirstWord Pharma

SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19

SAN DIEGO and BOSTON, March 23, 2020 (GLOBE NEWSWIRE) -- In response to the government call for rapid... See more »
October 21, 2019Medical Buyer

SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, To Board of Directors

SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-genera... See more »

SmartPharm Press Releases

June 25, 2019PR Newswire

SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer

CAMBRIDGE, Mass., June 25, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmace... See more »

Social Media

SmartPharm Headquarters

650 E. Kendall Street

Cambridge, Massachusetts02142

1-212-600-1902

Driving Directions »

Trending Companies

SmartPharm Summary

ABOUT

Overview

SmartPharm is a biotechnology firm that researches and develops gene-encoded therapeutic for the treatment of cancer and orphan diseases. SmartPharm was founded in 2017. SmartPharm's headquarters is located in Cambridge, Massachusetts, USA 02142. It h...

CEO

SmartPharm's President & CEO, Jose Trevejo, currently has an approval rating of 90%. SmartPharm's primary competitors are REGENXBIO, Recombinetics & Precision BioSciences.

Website

smartpharmtx.com

Frequently Asked Questions about SmartPharm

  1. When was SmartPharm founded?

    SmartPharm was founded in 2017

  2. Who is SmartPharm's CEO?

    SmartPharm's CEO is Jose Trevejo

  3. How much revenue does SmartPharm generate?

    SmartPharm generates $1.7M in revenue

  4. How much funding does SmartPharm have?

    SmartPharm has historically raised $10.7M in funding

  1. Where is SmartPharm's headquarters?

    SmartPharm's headquarters is in Cambridge Massachusetts, USA

  2. How many employees does SmartPharm have?

    SmartPharm has 25 employees

  3. What sector does SmartPharm operate in?

    SmartPharm is in Biotechnology

  4. Who are SmartPharm's competitors?

    SmartPharm's top competitors are REGENXBIO, Recombinetics, Precision BioSciences
Stay up-to-date with the latest news on SmartPharm

© 2021 Owler, Inc.